PIWIL2 / Piwi-like protein 2 · Western blot design guide

Design a Western Blot for PIWIL2

Source-linked PIWIL2 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PIWIL2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for PIWIL2: expected band ~109.8 kDa, hero antibody A04654-1, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable PIWIL2 Western blot protocol sheet — expected band ~109.8 kDa, antibody A04654-1, controls and PMC citations. Open the full PIWIL2 WB guide →

PIWIL2 Western Blot Experimental Design Guide

Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~109.8 kDa
Gel 8–10% (standard starting point)
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Methylated
Caveat Antibody identity mismatch
Gene-set association MSigDB C7 membership
Isoform 2 isoform(s)
Section 1

Source-Linked PIWIL2 Western Blot Protocol Options

The A04654-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysateHepG2 cell lysate (catalog A04654-1)
Gel %8–10% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferWet/tank transfer; optimize duration (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyA04654-1 · 1 μg/mL (catalog A04654-1)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected PIWIL2 Western Blot Band Size?

PIWIL2 is predicted at 109.8 kDa; alternative splicing could affect size, but no empirical migration or resolvable isoform pattern is supplied.

What am I looking at on my blot?
Single band near 109.8 kDaConsistent with the predicted PIWIL2 mass; confirm identity with controls
Several bands at different sizesIsoforms 1 and 2 could contribute, but distinct migration is unconfirmed
Band above 109.8 kDaIdentity and cause of the higher apparent mass require validation
Band below 109.8 kDaAn isoform is possible, but its mass and migration are unknown
💡Expected PIWIL2 appearanceFull-length PIWIL2 has a predicted mass of 109.8 kDa; no empirical band size is supplied, and isoform-dependent migration requires band-identity controls.
How each factor affects band size
Predicted PIWIL2 massPlaces the full-length reference near 109.8 kDa
Alternative splicingMay change protein size, but no isoform masses are supplied
Isoform 1Its individual apparent band size is unknown
Isoform 2Its size relative to isoform 1 is unknown
Why is my band missing or off?
SituationLikely causeNext action
No band in lysatePIWIL2 is associated with germ-cell structures, so the sample may have little expressionCheck expression in the sample and include a suitable positive control
Band higher than expectedNo supplied feature establishes an upward shiftVerify identity with PIWIL2 depletion and an independent antibody
Band lower than expectedAn isoform is possible, but no isoform mass is suppliedCheck antibody epitope coverage and confirm the band by PIWIL2 depletion
Multiple bandsIsoforms 1 and 2 may contribute; distinct migration is unconfirmedCompare epitope coverage and test which bands respond to PIWIL2 depletion
Weak or no signalLow PIWIL2 abundance in the sampled cells is possibleUse a suitable positive control and check sample expression

Sample controls for PIWIL2 Western blot

🧪For positive controls for PIWIL2 in Western blot, you can use a sample with independently confirmed PIWIL2 expression, since no HPA positive tissue or cell is supplied.
Positive control: No high/medium HPA tissue identified
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: PIWIL2 is cytoplasmic, but the supplied HPA record identifies no validated positive or negative tissue.

HPA tissue expression evidence for PIWIL2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
No high/medium HPA tissues identified in the supplied evidence.

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
No lower-expression tissue rows available in the supplied evidence.
Section 3

Advanced PIWIL2 Western Blot Tips

Deeper troubleshooting and optimisation questions for PIWIL2, answered from its protein features.

Where should the main PIWIL2 band appear?
Band shift · The predicted mass of canonical PIWIL2 is 109.8 kDa. No observed band position is supplied, so use this as a starting point and verify band identity independently; the listed features do not establish an apparent mass or a visible shift.
Could PIWIL2 isoforms produce different bands?
Isoforms · Yes. Isoform 2 lacks residues 887–922 relative to isoform 1, so it has a shorter sequence. The features do not establish whether the isoforms resolve as separate bands. Check which isoform your antibody recognizes before assigning a band.
Do annotated modifications prove a band shift?
PTM · The linked UniProt record describes protein features. A modification annotation alone does not demonstrate a visible shift; retain any condition or experimental qualifier attached to it.
Does this guide establish induction of PIWIL2?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
What transfer method to use for PIWIL2 Western blot?
Transfer · Choose and verify a transfer setup suitable for the predicted 109.8 kDa protein. Check protein transfer to the membrane and whether target-sized material remains in the gel. The supplied features do not specify a membrane type or transfer conditions.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A04654-1 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should total PIWIL2 and methylated PIWIL2 be quantified?
Quantitation · Measure total PIWIL2 and methylation-specific signal separately if both are of interest. Confirm that each antibody recognizes the intended sequence or modification, since PIWIL2 has two isoforms and several annotated arginine methylation sites. Compare like bands across samples; the features alone cannot identify which methylation states an antibody detects.
Which PIWIL2 methylation sites matter when interpreting bands?
Interpretation · UniProt lists symmetric dimethylarginine at residues 47, 146, 158, 165 and 551, plus alternate methylation states at 76, 97 and 102. PRMT5 is specified for methylation at 76, 97, 102, 165 and 551 as indicated by the individual annotations. These sites do not by themselves predict a visible band shift. Positions use the supplied UniProt sequence numbering.

Check whether an additional band is consistent with isoform 2, which lacks residues 887–922, and whether the antibody recognizes both isoforms. PIWIL2 also has annotated arginine methylation, but those features alone cannot explain a particular band shift. Confirm band identity before assigning either explanation.

PIWIL2 is annotated in the cytoplasm and noted as present in the chromatoid body, with a probable role in the meiotic nuage. A cytoplasmic fraction is therefore relevant when choosing samples. The supplied features do not establish detection levels in any particular tissue or preparation.
Boster reagents

PIWIL2 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of PIWI-L2 in HepG2 cell lysate with PIWI-L1 antibody at 1 μg/mL.
Anti-PIWI-L2 Antibody
Cat # A04654-1

The catalog reports one anti-PIWIL2 antibody, A04654-1, with stated human and mouse reactivity. Its WB caption reports HepG2 cell lysate at 1 μg/mL, but names a PIWI-L1 antibody, so the image’s antibody identity is unclear.

Which to pick: A04654-1 is the only listed option. It has a WB image with a reported HepG2 sample, but confirm the antibody used before relying on that image; the caption names PIWI-L1 despite the PIWI-L2 product name.

Source: BosterBio PIWIL2 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.